Retatrutide 20mg

$149.00

Retatrutide 20mg is a synthetic research peptide prepared for controlled laboratory investigation of coordinated GIP, GLP-1, and glucagon receptor activity. Its triple-agonist design gives researchers a focused material for examining how multiple metabolic signaling pathways interact within a single experimental system.

Download Certificate

Terms & Conditions

Privacy Policy

Research Use Disclaimer:
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.

Description

Each Owens Peptide Solutions vial contains 20mg of lyophilized Retatrutide for qualified analytical and preclinical research. Also referenced in scientific literature as LY3437943, Retatrutide is a single-molecule agonist designed to interact with glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors.

Research Use Disclaimer:

For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.

Its combined receptor profile distinguishes it from compounds limited to one or two incretin-related pathways. Laboratory studies have used Retatrutide to examine receptor potency, glucose-responsive signaling, metabolic pathway coordination, energy expenditure models, and peptide pharmacology.

Current findings depend on the selected research system and should not be interpreted as confirmed therapeutic or clinical outcomes.

Key Features

Triple-agonist structure: Engages GIP, GLP-1, and glucagon receptors.
20mg vial format: Supplies a measured quantity of research peptide.
Single-molecule compound: Combines three receptor activities in one sequence.
Advanced metabolic focus: Supports incretin and energy-signaling investigations.
Lyophilized presentation: Freeze-dried for controlled storage and preparation.
Traceable identification: Includes product and lot information.

Research Applications

Retatrutide may be incorporated into studies involving:

GIP, GLP-1, and glucagon receptor activation
Comparative receptor potency and selectivity
Incretin and glucagon pathway coordination
Glucose-dependent signaling responses
Energy balance and expenditure models
Peptide pharmacokinetic behavior

Experimental results may differ according to model type, study duration, concentration, analytical method, and laboratory conditions.

Storage Recommendations

Keep the unopened vial refrigerated at 2°C to 8°C.
Protect the lyophilized material from light, heat, and moisture.
Use validated frozen conditions for extended storage periods.
Minimize temperature fluctuations and repeated freeze-thaw exposure.
Follow institutional protocols and batch-specific documentation.

Package Contents

Each package contains:

20mg of lyophilized Retatrutide
One sealed research vial
Product and lot identification details
Protective packaging for secure handling

2 reviews for Retatrutide 20mg

Rated 5 out of 5

Dr. Naomi Feld – May 25, 2026

Ordered for a metabolic receptor study and everything arrived exactly as described.
Rated 4 out of 5

Gregory Paulsen – July 3, 2026

Good experience overall, will reorder for our next research cycle.

Only logged in customers who have purchased this product may leave a review.